Buyside Needs Tech, Exemptions To Clear OTC Derivatives

Buy-side firms will need new technology and regulatory exemptions before they can effectively access central counterparty clearing (CCP) platforms for over-the-counter derivatives directly, according to Ila Eckhoff, director at BlackRock.